4.32

3.60% 0.15

After Hours: 4.35 0.03 +0.69%

Orasure Technologies Inc (OSUR)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Orasure Technologies Inc stock is traded at $4.32, with a volume of 657.57K. It is up +3.60% in the last 24 hours and up +44.00% over the past month. OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.

Previous Close:

$4.17

Open:

$4.19

24h Volume:

657.57K

Relative Volume:

1.08

Market Cap:

$297.43M

Revenue:

$113.02M

Net Income/Loss:

$-75.07M

P/E Ratio:

-4.1431

EPS:

-1.0427

Net Cash Flow:

$-47.88M

1W Performance:

+1.89%

1M Performance:

+44.00%

6M Performance:

+78.51%

1Y Performance:

+50.00%

1-Day Range:

$4.01

$4.355

1-Week Range:

$4.00

$4.355

52-Week Range:

$2.08

$4.355

Orasure Technologies Inc Stock (OSUR) Company Profile

Name

Orasure Technologies Inc

Sector

Healthcare (1107)

Industry

Medical Instruments & Supplies (56)

Phone

(503) 641-6115

Address

220 E FIRST ST, BETHLEHEM, PA

Employee

500

Twitter

@orasure

Next Earnings Date

2026-08-04

Latest SEC Filings

OSUR's Discussions on Twitter

Compare OSUR vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OSUR Orasure Technologies Inc	4.32	287.10M	113.02M	-75.07M	-47.88M	-1.0427
ISRG Intuitive Surgical Inc	417.07	147.53B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	145.16	40.10B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	65.84	32.33B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	37.09	31.57B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	193.94	27.96B	5.54B	1.52B	1.74B	10.37

Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-03-23	Resumed	Evercore ISI	In-line
Sep-22-21	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-21-20	Initiated	Evercore ISI	Outperform
Aug-10-20	Initiated	Citigroup	Buy
Aug-10-20	Initiated	JP Morgan	Neutral
Aug-07-20	Upgrade	Raymond James	Mkt Perform → Outperform
Jun-25-20	Initiated	Lake Street	Buy
Apr-21-20	Resumed	Stephens	Equal-Weight
Oct-23-18	Resumed	Raymond James	Mkt Perform
Jul-16-18	Downgrade	Stephens	Overweight → Equal-Weight
Nov-02-17	Downgrade	Jefferies	Buy → Hold
Feb-09-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jun-13-16	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-05-15	Reiterated	Mizuho	Buy
May-07-15	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jan-23-15	Reiterated	Mizuho	Buy
Jun-12-14	Reiterated	Canaccord Genuity	Buy
Jun-11-14	Reiterated	Mizuho	Buy
Dec-21-12	Initiated	Mizuho	Buy
Aug-08-12	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-05-12	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-27-12	Initiated	JMP Securities	Mkt Outperform

View All

Orasure Technologies Inc Stock (OSUR) Latest News

Jun 11, 2026

OraSure receives FDA clearance for home urine collection kit for STIs - Lehigh Valley Business

Jun 11, 2026

OraSure secures FDA clearance for product seen as key to future growth - WFMZ.com

Jun 11, 2026

OraSure stock jumps on FDA clearance for at-home STI kit - Investing.com

Jun 11, 2026

OraSure stock jumps on FDA clearance for at-home STI kit By Investing.com - Investing.com South Africa

Jun 11, 2026

OraSure Technologies (NASDAQ: OSUR) wins FDA clearance for Colli-Pee Dx at-home urine collection kit - Stock Titan

Jun 11, 2026

OraSure gets FDA nod for at-home STI urine collection kit By Investing.com - Investing.com Australia

Jun 11, 2026

OraSure gets FDA nod for at-home STI urine collection kit - Investing.com India

Jun 11, 2026

OraSure receives FDA clearance for at-home STI urine collection kit - StreetInsider

Jun 11, 2026

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections - The Manila Times

Jun 11, 2026

FDA clears at-home urine kit that lets labs test for 4 STIs by mail - Stock Titan

Jun 11, 2026

Jun 07, 2026

OraSure Technologies (OSUR) Slips 3.1% as Stock Tests Key Support LevelOvernight Profile - newsline.com

Jun 07, 2026

Is Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now? - Yahoo Finance

Jun 07, 2026

Jun 05, 2026

OraSure Technologies (OSUR) director receives 46,106-share restricted stock grant - Stock Titan

Jun 05, 2026

OraSure (OSUR) director Nancy Gagliano receives 46,106-share stock award - Stock Titan

Jun 05, 2026

OraSure Technologies (OSUR) director receives 46,106-share stock grant - Stock Titan

Jun 05, 2026

OraSure (OSUR) director John P. Kenny granted 46,106 restricted shares - Stock Titan

Jun 05, 2026

Director at OraSure (NASDAQ: OSUR) receives 46,106 restricted shares - Stock Titan

Jun 05, 2026

Jun 04, 2026

Earnings call transcript: OraSure Technologies Q1 2026 misses earnings and revenue forecasts - Investing.com UK

Jun 04, 2026

OraSure Technologies Investors Approve Expanded Stock Plan, Governance Changes - The Globe and Mail

Jun 04, 2026

Jun 03, 2026

OraSure Technologies (NASDAQ: OSUR) OKs more equity awards and board declassification - Stock Titan

Jun 03, 2026

May 29, 2026

OraSure Technologies Hits New 52-Week High of $4.33, Marking Significant Growth - Markets Mojo

May 29, 2026

OSUR Q1 2026 Earnings: EPS Miss by 69% Signals Operational HeadwindsFree Cash Flow Trends - newsline.com

May 29, 2026

May 28, 2026

OraSure Technologies, Inc.Common Stock (NQ: OSUR - FinancialContent

May 28, 2026

OraSure Technologies (OSUR) Gains 6%: Testing Resistance as Momentum BuildsEase of Movement - The Legal Advocate

May 28, 2026

OraSure Technologies Hits New 52-Week High at $4.00 - Markets Mojo

May 28, 2026

Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com

May 28, 2026

OraSure Technologies Hits New 52-Week High at $4.12 - MarketsMojo

May 28, 2026

Is Co-Diagnostics National Security’s Next Diagnostic Pick? - MarketBeat

May 28, 2026

May 27, 2026

OraSure Technologies (OSUR) Gains 3.68% as Stock Approaches Key Resistance LevelNHNL Divergence - The Legal Advocate

May 27, 2026

OraSure Technologies (OSUR) price target increased by 25.00% to 5.10 - MSN

May 27, 2026

Insiders Buying OraSure Technologies Might Wish They Invested More, Stock Gains 28% - Moomoo

May 27, 2026

May 26, 2026

OraSure Technologies (OSUR) Surges 9%: Key Levels to Watch After Strong MoveBearish Pattern Stocks - The Legal Advocate

May 26, 2026

May 24, 2026